Eric D. Donnenfeld, MD; discusses the importance of understanding the pathogenesis of Demodex blepharitis to reach a proper diagnosis. This is a video synopsis/summary of an Insights involving Eric D.

After FDA approval, XDEMVY is available for prescription nationwide to target Demodex mites, the primary cause of the external eye disease Demodex blepharitis. The FDA approved XDEMVY (lotilaner ...

Approximately 25 million eye care patients in the U.S. suffer from Demodex blepharitis, an eyelid disease characterized by inflammation, redness, and ocular irritation. 1-2 Demodex blepharitis is ...

Modern Vision Solutions has announced the publication of a new article, “Demodex Blepharitis Treatment in Omaha,” highlighting a significant shift in how optometrists approach the treatment of chronic ...

The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites. The approval was based on ...

Add Yahoo as a preferred source to see more of our stories on Google. Waking up with some gunk in your eyes is usually nothing to worry about. The scientific name for this crust is rheum, and it forms ...

Please provide your email address to receive an email when new articles are posted on . The “Mite Party” campaign is designed to raise awareness about Demodex blepharitis. Tarsus launched the campaign ...

John Cena opens up about his overlooked eye disease and the diagnosis that changed his approach to health.